about
An open-label study of amisulpride in the treatment of mania[Suicide mortality in Olot from 1936 until 2000]Psychoeducation in bipolar disorder with a SIMPLe smartphone application: Feasibility, acceptability and satisfaction.The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: the 32 item hypomania symptom check list (HCL-32).Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.Validation of the Portuguese version of the Lithium Attitudes Questionnaire (LAQ) in bipolar patients treated with lithium: cross-over studyAcute and long-term treatment of mania.Adaptation and validation of the Portuguese version of the Lithium Knowledge Test (LKT) of bipolar patients treated with lithium: cross-over study.Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder.Treatment guidelines for bipolar disorder: a critical review.Identifying and improving non-adherence in bipolar disorders.Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review.Functioning and disability in bipolar disorder: an extensive review.Treatment-resistant bipolar depression: towards a new definition.The clinical implications of cognitive impairment and allostatic load in bipolar disorder.Depressive disorders and suicide: Epidemiology, risk factors, and burden.Psychosocial interventions in bipolar disorder: what, for whom, and when.High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment.Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives.The role of family interventions in bipolar disorder: A systematic review.Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies.Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study.Treatment of Functional Impairment in Patients with Bipolar Disorder.Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?Evaluation of Patient Satisfaction in a State Reference Center of Bipolar Disorder.1-year follow-up of patients treated with risperidone and topiramate for a manic episode.Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use.Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode.Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial.Adaptation and validation of the Spanish version of the Mood Disorder Questionnaire for the detection of bipolar disorder.Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome.Psychotic versus non-psychotic bipolar II disorder.Acute and continuation risperidone monotherapy in mania.Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome.Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study.Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.
P50
Q28250310-F558F94C-FD1E-47EA-97B8-35C99EB1672DQ30953023-61BDD97E-B108-4CB0-BFF2-02195506B70DQ33448472-E9F62273-409A-4D84-8CBB-4C4F6F61A853Q33605308-536989DF-2FAA-462F-8A93-501B2D818AD0Q34307557-701D4CCF-9E6E-4F87-B6AC-752A3FDFCE11Q34566918-57BEE6A4-0B53-425A-837E-D4DBFE622A73Q34594801-DD9E178C-F065-4D21-AB72-DB05F7896338Q34994544-19D5AD95-D5CE-4292-8EB4-67B5D8953843Q35171922-FA2C749F-3FDB-40C1-89DC-F24FA636CF59Q35236966-52447595-03F8-4F19-A134-74912727B878Q35250739-1FE90BC3-2652-4125-9830-9E43B39948DDQ35865593-2CEFAEAA-9533-4762-8C6A-6DA4FDA6F964Q36093544-F2D7852E-E594-4C39-A85D-B06CEA3CB35AQ36286408-B9655DE2-1B34-4DB3-BB14-C8052241F9E3Q37171035-F769BEF2-44F6-4874-B608-FCF4CDCF9E3BQ37201058-7F29E842-88E2-487F-AE68-771BA7E147C8Q37551519-259F000A-6B95-446C-8A34-8D434218A392Q37594155-C2208DC9-6802-444D-BACE-EE34DFB2D7DBQ38005559-E2190BFB-5036-4883-813E-236A6361F3A3Q38073521-132975B9-0F22-46AA-8A6F-8DF050664F4CQ38179672-0D3F124B-5768-4DA4-BAA0-9E8587D47292Q38383039-AE80CDB7-B7D1-4F64-A2CF-50DC3A86EF5AQ38666559-6EB7600D-71B9-4C75-B345-C351582827EFQ38675731-7C37E012-4702-4F43-8F07-F8C52985522CQ38789179-CE5430DE-D575-4A82-81BD-292553254F0AQ38882428-B1874AEE-333F-4CEA-8106-2FC2549945ACQ39093204-BD46304D-D9CD-4086-9945-405E40C25F50Q40085552-0F2A10BE-B9EA-4321-AB5D-467681540864Q40123186-33C2A742-2069-4FD5-956E-0C1A8BC0EA26Q42606787-C61BE909-937F-4104-9D0C-AAEF412CEC50Q43275792-2B413F17-AC15-4B46-BE2F-00F1259FFF97Q43825121-BCE35AAF-0D9B-4C70-B470-2B22F70163FEQ44048838-1F8226CA-DDA2-4FB3-84EC-E75F5397472FQ44261251-A8F272EA-40E0-4F81-80B1-35D2C28D3969Q44291529-6DE256BF-A2D7-4A54-8F71-00E1E5D9C3F2Q44385085-9E198EBA-A645-4A1F-B17E-504A5769C3C8Q44723795-412DB10C-684F-4BD3-B747-83D4BCAB4AC1Q44874580-FEAD2E94-81A4-44DA-94CA-AFD55053CBB8Q44920935-CE020F7C-4F5B-41BB-904E-1823B0F71FBDQ44962387-057076B2-F709-4CFA-AD38-BCA3B1A27E80
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Jose Sanchez-Moreno
@ast
Jose Sanchez-Moreno
@en
Jose Sanchez-Moreno
@es
Jose Sanchez-Moreno
@nl
Jose Sanchez-Moreno
@sl
type
label
Jose Sanchez-Moreno
@ast
Jose Sanchez-Moreno
@en
Jose Sanchez-Moreno
@es
Jose Sanchez-Moreno
@nl
Jose Sanchez-Moreno
@sl
prefLabel
Jose Sanchez-Moreno
@ast
Jose Sanchez-Moreno
@en
Jose Sanchez-Moreno
@es
Jose Sanchez-Moreno
@nl
Jose Sanchez-Moreno
@sl
P214
P950
P1053
N-3194-2014
P106
P1153
6602478015
P21
P214
P31
P3829
P496
0000-0003-1520-093X
P569
2000-01-01T00:00:00Z
P735
P7859
viaf-169086774